C1QL3
Complement C1q-like protein 3
Also known as: C1ql, C1QL3_HUMAN, C1QTNF13, CTRP13, K100
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VWW1
- Gene
- C1QL3
- Ensembl
- ENSG00000165985
- Chromosome
- 10
- Canonical length
- 255 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Vesicles,Cytosol
- Secretome location
- Secreted in brain
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Predicted to enable identical protein binding activity. Predicted to be involved in neurotransmitter receptor localization to postsynaptic specialization membrane and postsynaptic density assembly. Predicted to act upstream of or within regulation of synapse organization. Predicted to be located in extracellular region. Predicted to be part of collagen trimer. Predicted to be active in glutamatergic synapse; hippocampal mossy fiber to CA3 synapse; and synaptic cleft. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
255 residues, UniProt reviewed canonical sequence.
>Q5VWW1|C1QL3
1 MVLLLVILIP VLVSSAGTSA HYEMLGTCRM VCDPYGGTKA PSTAATPDRG LMQSLPTFIQ
61 GPKGEAGRPG KAGPRGPPGE PGPPGPMGPP GEKGEPGRQG LPGPPGAPGL NAAGAISAAT
121 YSTVPKIAFY AGLKRQHEGY EVLKFDDVVT NLGNHYDPTT GKFTCSIPGI YFFTYHVLMR
181 GGDGTSMWAD LCKNNQVRAS AIAQDADQNY DYASNSVVLH LEPGDEVYIK LDGGKAHGGN
241 NNKYSTFSGF IIYADLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C1QL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 26 nTPM
- retina: 6.9 nTPM
- cerebellum: 4.8 nTPM
- hippocampal formation: 4.2 nTPM
- amygdala: 3.3 nTPM
- hypothalamus: 2.3 nTPM
Single-cell type
- rod photoreceptor cells: 17 nCPM
- cardiomyocytes: 16 nCPM
- brain excitatory neurons: 13 nCPM
- epicardial cells: 9.1 nCPM
- retinal ganglion cells: 7.7 nCPM
- myonuclei: 7.5 nCPM
Immune cell
- naive CD8 T-cell: 0.5 nTPM
- gdT-cell: 0.4 nTPM
- intermediate monocyte: 0.4 nTPM
- T-reg: 0.4 nTPM
- memory CD4 T-cell: 0.3 nTPM
- memory CD8 T-cell: 0.3 nTPM
Brain region
- hippocampal formation: 145 nTPM
- cerebral cortex: 123 nTPM
- basal ganglia: 121 nTPM
- amygdala: 102 nTPM
- white matter: 53 nTPM
- thalamus: 37 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0.52
- gnomAD missense Z
- 2.12
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 0% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- neurotransmitter receptor localization to postsynaptic specialization membrane
- postsynaptic density assembly
- regulation of synapse organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of C1QL3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C1QL3 as an antibody target. Whether an autoantibody or antibody against C1QL3 could matter depends on whether native C1QL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C1QL3 is annotated as secreted, so native C1QL3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label C1QL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...